Select a Sector or Industry
Long Term Debt Rankings for Diagnostic Substances Industry
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Long Term Debt
|
Pro Rating
|
|---|---|---|---|---|
| 1 | SRDX | SurModics | 0.00 | Go Pro |
| 1 | NEOG | Neogen Corporation | 0.00 | Go Pro |
| 1 | APPY | AspenBio Pharma | 0.00 | Go Pro |
| 1 | VIVO | Meridian Bioscience | 0.00 | Go Pro |
| 1 | PTN | Palatin Technologies | 0.00 | Go Pro |
| 1 | VRML | Vermillion | 0.00 | Go Pro |
| 1 | AMAG | AMAG Pharmaceuticals | 0.00 | Go Pro |
| 1 | TRIB | Trinity Biotech | 0.00 | Go Pro |
| 1 | NYMX | Nymox Pharmaceutical Corporation | 0.00 | Go Pro |
| 1 | AXK | Accelr8 Technology | 0.00 | Go Pro |
| 1 | TKMR | Tekmira Pharmaceuticals | 0.00 | Go Pro |
| 1 | ICCC | ImmuCell Corporation | 0.00 | Go Pro |
| 1 | ROSG | Rosetta Genomics | 0.00 | Go Pro |
| 14 | RPTP | Raptor Pharmaceutical | 0.0077M | Go Pro |
| 15 | ABAX | ABAXIS | 0.783M | Go Pro |
| 16 | IDXX | IDEXX Laboratories | 3.194M | Go Pro |
| 17 | CLDX | Celldex Therapeutics | 15.18M | Go Pro |
| 18 | SNTA | Synta Pharmaceuticals | 16.48M | Go Pro |
| 19 | QDEL | Quidel Corporation | 25.20M | Go Pro |
